Remove tag expanded-access-programmes
article thumbnail

No sign of stopping: The rise of cell and gene therapy

Drug Discovery World

But are these price tags a barrier to access? Biotech and pharma are actively working with payers and insurers to deliver on equitable pricing models that ensure access. It is imperative that these payment processes are supported to expand access. million per dose.